Skip to main content
Diamines & Chemicals Ltd. logo

Diamines & Chemicals Ltd. — Investor Relations & Filings

Ticker · DIAMINESQ ISIN · INE591D01014 LEI · 335800AQNIZET87LXI95 BSE.NS Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2026-05-30 Regulatory Filings
Country IN India
Listing BSE.NS DIAMINESQ

About Diamines & Chemicals Ltd.

https://dacl.co.in/

Diamines & Chemicals Ltd. specializes in the production of ethylene amines and related chemical intermediates. The company’s core product portfolio includes Ethylenediamine (EDA), Diethylenetriamine (DETA), Triethylenetetramine (TETA), Tetraethylenepentamine (TEPA), and Piperazine. These specialty chemicals are utilized across diverse sectors, including pharmaceuticals, agrochemicals, polyamide resins, and water treatment. The firm operates integrated manufacturing facilities designed for the synthesis of high-purity organic compounds. By leveraging advanced chemical processes, it provides essential raw materials for applications in oilfield chemicals, textile auxiliaries, and paper chemicals. The organization maintains a focus on technical excellence and process innovation to meet the stringent requirements of global supply chains.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 85% confidence The document is a letter to BSE and NSE under SEBI Listing Regulation 30 enclosing copies of a newspaper notice regarding share transfers to the IEPF. It is a routine regulatory disclosure rather than a financial report or corporate action (e.g., dividend, board change, M&A). Therefore it falls under the generic regulatory announcements category.
2026-05-30 English
We submit herewith copies of Notice published in Newspapers regarding transfer of shares of the Company to the Investor Education and Protection Fund.
Regulatory Filings Classification · 85% confidence The document is an SEBI LODR “Regulation 30” intimation and includes newspaper notices (in English and Gujarati) regarding transfer of shares to the IEPF plus an extract of audited quarterly/year-end results published in a paper. It is neither a full report (e.g., 10-K, IR) nor a specific event like dividends or M&A, but a routine compliance/regulatory announcement under listing rules. This falls into the general Regulatory Filings category (RNS).
2026-05-30 English
We submit herewith Annual Secretarial Compliance Report for the FY 2025-26.
Regulatory Filings Classification · 85% confidence The document is a submission to stock exchanges of the Annual Secretarial Compliance Report under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It is a compliance certificate by practicing company secretaries regarding SEBI LODR compliance, not the company’s full Annual Report, earnings release, or financial statements. This falls under general regulatory/compliance filings. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-05-30 English
General Updates
Regulatory Filings Classification · 92% confidence The document is a formal regulatory disclosure under SEBI (Listing Obligations & Disclosure Requirements) Regulation 30 notifying the stock exchanges and shareholders about transfer of shares with unclaimed dividends to the Investor Education and Protection Fund. It does not present financial statements or qualify as a dividend declaration, nor is it a full annual/interim report, a capital change (e.g., share issue), or a proxy solicitation. It is an operational/ regulatory announcement and therefore falls under the fallback category “Regulatory Filings (RNS).”
2026-05-29 English
We submit herewith copy of notices sent to the shareholders, who have not claimed or encashed their dividend for seven or more consequent years.
Regulatory Filings Classification · 85% confidence The document is an intimation submitted to BSE and NSE under Regulation 30 of SEBI (LODR) notifying shareholders and the exchanges about the transfer of unclaimed‐dividend shares to the IEPF. It does not contain any financial statements or key highlights of earnings, nor is it a proxy, dividend declaration, management change, or actual financial report. It is a mandatory regulatory disclosure/compliance filing to the stock exchanges, falling under the general “Regulatory Filings” category (RNS).
2026-05-29 English
We submit herewith statement of Deviation & variation under Reg 32 of SEBI LODR, 2015
Regulatory Filings Classification · 80% confidence The document is a mandatory SEBI listing compliance disclosure under Regulation 32(1) reporting the statement of deviation/variation in the utilisation of preferential issue funds for the quarter ended March 31, 2026. It does not contain financial statements or substantive financial analysis, nor is it a summary investor presentation or board change notice. It is a regulatory compliance filing. Therefore it falls under the fallback category Regulatory Filings (RNS).
2026-05-18 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.